155 related articles for article (PubMed ID: 1751598)
21. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
Honkanen E; Kala AR; Grönhagen-Riska C; Ikäheimo R
Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
[TBL] [Abstract][Full Text] [Related]
22. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].
Jovanović N; Lausević M; Stojimirović B
Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245
[TBL] [Abstract][Full Text] [Related]
23. Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study.
Lee YK; Choi HY; Shin SK; Lee HY
Clin Nephrol; 2013 Feb; 79(2):136-42. PubMed ID: 23211335
[TBL] [Abstract][Full Text] [Related]
24. The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD.
Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
Perit Dial Int; 1996; 16 Suppl 1():S567-9. PubMed ID: 8728272
[TBL] [Abstract][Full Text] [Related]
25. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
[TBL] [Abstract][Full Text] [Related]
26. Low calcium dialysate and hyperparathyroidism.
Duncan R; Cochrane T; Bhalla C; Michael J; Richards NT; Adu D
Perit Dial Int; 1996; 16 Suppl 1():S499-502. PubMed ID: 8728256
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis.
Jin L; Zhou J; Shao F; Yang F
BMC Nephrol; 2019 Jun; 20(1):213. PubMed ID: 31185931
[TBL] [Abstract][Full Text] [Related]
28. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
29. [Relative hypoparathyroidism associated with CAPD treatment using normo-calcemic (3.5mEq/1) dialysate: an approach from transperitoneal calcium balance].
Shigematsu T; Hasegawa T; Utsunomiya M; Kubo H; Kato N; Hayakawa H; Yamamoto H; Nakayama M; Ogawa A; Kawaguchi Y
Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):172-8. PubMed ID: 7731105
[TBL] [Abstract][Full Text] [Related]
30. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
Hutchison AJ; Freemont AJ; Boulton HF; Gokal R
Nephrol Dial Transplant; 1992; 7(12):1219-25. PubMed ID: 1337163
[TBL] [Abstract][Full Text] [Related]
31. The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
Yokoyama K; Kagami S; Ohkido I; Kato N; Yamamoto H; Shigematsu T; Nakayama M; Fukagawa M; Kawaguchi Y; Hosoya T
Nephron; 2002 Sep; 92(1):86-90. PubMed ID: 12187089
[TBL] [Abstract][Full Text] [Related]
32. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
[TBL] [Abstract][Full Text] [Related]
33. Calcium-phosphate and parathyroid intradialytic profiles: A potential aid for tailoring the dialysate calcium content of patients on different hemodialysis schedules.
Ferraresi M; Pia A; Guzzo G; Vigotti FN; Mongilardi E; Nazha M; Aroasio E; Gonella C; Avagnina P; Piccoli GB
Hemodial Int; 2015 Oct; 19(4):572-82. PubMed ID: 25819092
[TBL] [Abstract][Full Text] [Related]
34. Reduced calcium dialysate in CAPD patients: efficacy and limitations.
Armstrong A; Beer J; Noonan K; Cunningham J
Nephrol Dial Transplant; 1997 Jun; 12(6):1223-8. PubMed ID: 9198055
[TBL] [Abstract][Full Text] [Related]
35. Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients?
Rotellar C; Kinsel V; Goggins M; Tarman G; Stull M; Mazzoni MJ; Mosher WF; Rakowski TA; Winchester JF
Perit Dial Int; 1993; 13 Suppl 2():S471-2. PubMed ID: 8399643
[TBL] [Abstract][Full Text] [Related]
36. Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients.
Takahashi S; Okada K; Yanai M
Perit Dial Int; 1994; 14(1):75-8. PubMed ID: 8312420
[TBL] [Abstract][Full Text] [Related]
37. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
38. The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients.
Oettinger CW; Oliver JC; Macon EJ
J Am Soc Nephrol; 1992 Oct; 3(4):995-1001. PubMed ID: 1450373
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism.
Slatopolsky E; Weerts C; Norwood K; Giles K; Fryer P; Finch J; Windus D; Delmez J
Kidney Int; 1989 Nov; 36(5):897-903. PubMed ID: 2615197
[TBL] [Abstract][Full Text] [Related]
40. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.
Mornière P; Maurouard C; Boudailliez B; Westeel PF; Achard JM; Boitte F; el Esper N; Compagnon M; Maurel G; Bouillon R
Nephron; 1992; 60(2):154-63. PubMed ID: 1552999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
